Loss of miR-10a Activates Lpo and Collaborates with Activated Wnt Signaling in Inducing Intestinal Neoplasia in Female Mice

PLoS Genetics

Volumn 9, Issue 10, 2013, Pages

  Stadthagen, Gustavo ^a   Tehler, Disa ^a   Høyland Kroghsbo, Nina Molin ^a   Wen, Jiayu ^b   Krogh, Anders ^b   Jensen, Klaus T ^a   Santoni Rugiu, Eric ^c   Engelholm, Lars H ^b   Lund, Anders H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; LACTOPEROXIDASE; MICRORNA; MICRORNA 10A; UNCLASSIFIED DRUG; KRUPPEL LIKE FACTOR; MIRN10 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE INACTIVATION; GENE TARGETING; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; INTESTINE CANCER; INTESTINE EPITHELIUM; MALE; MOUSE; NONHUMAN; TUMOR VOLUME; UPREGULATION; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; INTESTINE TUMOR; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; WNT SIGNALING PATHWAY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; INTESTINAL NEOPLASMS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LACTOPEROXIDASE; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; WNT SIGNALING PATHWAY;

EID: 84887316302     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003913     Document Type: Article

References (77)

1. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
2. Paranjape T, Slack FJ, Weidhaas JB, (2009) MicroRNAs: tools for cancer diagnostics. Gut 58: 1546-1554.
3. Deng S, Calin GA, Croce CM, Coukos G, Zhang L, (2008) Mechanisms of microRNA deregulation in human cancer. Cell Cycle 7: 2643-2646.
4. Tehler D, Hoyland-Kroghsbo NM, Lund AH, (2011) The miR-10 microRNA precursor family. RNA Biol 8: 728-734.
5. Lund AH, (2010) miR-10 in development and cancer. Cell Death Differ 17: 209-214.
6. Mansfield JH, Harfe BD, Nissen R, Obenauer J, Srineel J, et al. (2004) MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet 36: 1079-1083.
7. Woltering JM, Durston AJ, (2008) MiR-10 represses HoxB1a and HoxB3a in zebrafish. PLoS One 3: e1396.
8. Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, et al. (2006) MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A 103: 5078-5083.
9. Han L, Witmer PD, Casey E, Valle D, Sukumar S, (2007) DNA methylation regulates MicroRNA expression. Cancer Biol Ther 6: 1284-1288.
10. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
11. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
12. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
13. Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, Bandres E, et al. (2008) Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 6: 1830-1840.
14. Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, et al. (2009) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137: 2136-2137, 2136-2145, e2131-2137.
15. Moriarty CH, Pursell B, Mercurio AM, (2010) miR-10b targets Tiam1: implications for Rac activation and carcinoma migration. J Biol Chem 285: 20541-20546.
16. Chai G, Liu N, Ma J, Li H, Oblinger JL, et al. (2010) MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 101: 1997-2004.
17. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
18. van den Brink GR, Offerhaus GJ, (2007) The morphogenetic code and colon cancer development. Cancer Cell 11: 109-117.
19. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science 253: 661-665.
20. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, et al. (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1: 229-233.
21. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669.
22. Markowitz SD, Bertagnolli MM, (2009) Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 361: 2449-2460.
23. Markowitz SD, Dawson DM, Willis J, Willson JK, (2002) Focus on colon cancer. Cancer Cell 1: 233-236.
24. Monzo M, Navarro A, Bandres E, Artells R, Moreno I, et al. (2008) Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 18: 823-833.
25. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
26. Schwenk F, Baron U, Rajewsky K, (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23: 5080-5081.
27. Moser AR, Pitot HC, Dove WF, (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324.
28. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.
29. Gould KA, Dietrich WF, Borenstein N, Lander ES, Dove WF, (1996) Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Genetics 144: 1769-1776.
30. Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P, et al. (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 17: 88-91.
31. Silverman KA, Koratkar R, Siracusa LD, Buchberg AM, (2002) Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res 12: 88-97.
32. Baran AA, Silverman KA, Zeskand J, Koratkar R, Palmer A, et al. (2007) The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. Genome Res 17: 566-576.
33. Hursting SD, Slaga TJ, Fischer SM, DiGiovanni J, Phang JM, (1999) Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst 91: 215-225.
34. Hatziapostolou M, Iliopoulos D, (2011) Epigenetic aberrations during oncogenesis. Cell Mol Life Sci 68: 1681-1702.
35. Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
36. Huntzinger E, Izaurralde E, (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12: 99-110.
37. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
38. Wilson PA, Plucinski M, (2011) A simple Bayesian estimate of direct RNAi gene regulation events from differential gene expression profiles. BMC Genomics 12: 250.
39. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
40. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
41. Ihalin R, Loimaranta V, Tenovuo J, (2006) Origin, structure, and biological activities of peroxidases in human saliva. Arch Biochem Biophys 445: 261-268.
42. Hamon CB, Klebanoff SJ, (1973) A peroxidase-mediated, streptococcus mitis-dependent antimicrobial system in saliva. J Exp Med 137: 438-450.
43. Josephy PD, (1996) The role of peroxidase-catalyzed activation of aromatic amines in breast cancer. Mutagenesis 11: 3-7.
44. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, et al. (1997) Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 94: 10937-10942.
45. Gorlewska-Roberts KM, Teitel CH, Lay JO Jr, Roberts DW, Kadlubar FF, (2004) Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines. Chem Res Toxicol 17: 1659-1666.
46. Bolton JL, Thatcher GR, (2008) Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol 21: 93-101.
47. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, et al. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766: 63-78.
48. Grady WM, Carethers JM, (2008) Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135: 1079-1099.
49. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
50. Bryant A, Palma CA, Jayaswal V, Yang YW, Lutherborrow M, et al. (2012) miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death. Mol Cancer 11: 8.
51. McConnell BB, Ghaleb AM, Nandan MO, Yang VW, (2007) The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29: 549-557.
52. Hu R, Zuo Y, Zuo L, Liu C, Zhang S, et al. (2011) KLF4 Expression Correlates with the Degree of Differentiation in Colorectal Cancer. Gut Liver 5: 154-159.
53. Hornstein E, Shomron N, (2006) Canalization of development by microRNAs. Nat Genet 38 Suppl: S20-24.
54. Miska EA, Alvarez-Saavedra E, Abbott AL, Lau NC, Hellman AB, et al. (2007) Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet 3: e215.
55. Mendell JT, Olson EN, (2012) MicroRNAs in stress signaling and human disease. Cell 148: 1172-1187.
56. Reiter B, Marshall VM, Philips SM, (1980) The antibiotic activity of the lactoperoxidase-thiocyanate-hydrogen peroxide system in the calf abomasum. Res Vet Sci 28: 116-122.
57. Gothefors L, Marklund S, (1975) Lactoperoxidase activity in human milk and in saliva of newborn infants. Infect Immun 11: 1210-1215.
58. Leigh JA, Field TR, Williams MR, (1990) Two strains of Streptococcus uberis, of differing ability to cause clinical mastitis, differ in their ability to resist some host defence factors. Res Vet Sci 49: 85-87.
59. Kim BW, Esworthy RS, Hahn MA, Pfeifer GP, Chu FF, (2012) Expression of lactoperoxidase in differentiated mouse colon epithelial cells. Free Radic Biol Med 52: 1569-1576.
60. Furtmuller PG, Jantschko W, Regelsberger G, Jakopitsch C, Arnhold J, et al. (2002) Reaction of lactoperoxidase compound I with halides and thiocyanate. Biochemistry 41: 11895-11900.
61. Li KM, Todorovic R, Devanesan P, Higginbotham S, Kofeler H, et al. (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25: 289-297.
62. Zahid M, Kohli E, Saeed M, Rogan E, Cavalieri E, (2006) The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem Res Toxicol 19: 164-172.
63. Saeed M, Rogan E, Cavalieri E, (2009) Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens. Int J Cancer 124: 1276-1284.
64. Fernandez SV, Russo IH, Russo J, (2006) Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer 118: 1862-1868.
65. Luo G, Santoro IM, McDaniel LD, Nishijima I, Mills M, et al. (2000) Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 26: 424-429.
66. Rudolph KL, Millard M, Bosenberg MW, DePinho RA, (2001) Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 28: 155-159.
67. Goss KH, Risinger MA, Kordich JJ, Sanz MM, Straughen JE, et al. (2002) Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297: 2051-2053.
68. Mann MB, Hodges CA, Barnes E, Vogel H, Hassold TJ, et al. (2005) Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome. Hum Mol Genet 14: 813-825.
69. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R, (2008) miR-148 targets human DNMT3b protein coding region. RNA 14: 872-877.
70. Forman JJ, Legesse-Miller A, Coller HA, (2008) A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 105: 14879-14884.
71. Orom UA, Nielsen FC, Lund AH, (2008) MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30: 460-471.
72. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I, (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
73. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
74. Roberts AP, Lewis AP, Jopling CL, (2011) miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 39: 7716-29.
75. Xue X, Feng T, Yao S, Wolf KJ, Liu CG, et al. (2011) Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40. J Immunol 187: 5879-5886.
76. Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, et al. (2010) p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 17: 236-245.
77. Smyth GK, Michaud J, Scott HS, (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075.